Baudax Bio
Diane M. has a strong background in regulatory and quality roles within the pharmaceutical industry. Diane is currently the Senior Vice President of Regulatory & Quality at Baudax Bio, a position they have held since November 2019. Prior to this, they had a long tenure at Recro Pharma, Inc. where they also served as the Senior Vice President of Regulatory & Quality from October 2008 to November 2019. Before Recro Pharma, Inc., they held the role of Vice President of Quality & Regulatory Affairs at Auxilium Pharmaceuticals from March 2000 to September 2008. Diane began their career at GlaxoSmithKline, where they held various roles including Quality Assurance Manager, Quality Control Biochemistry Supervisor, and Senior/Lead Quality Control Analyst.
Diane M. attended Neumann University from 1981 to 1985, where they pursued a Bachelor of Science degree in Biology.
This person is not in any teams
Baudax Bio
Baudax Bio is a revenue-generating, specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings. The Company has multiple non-opioid therapeutics in clinical development for the treatment of pain conditions and is currently promoting their lead product, ANJESO™, indicated for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.